{"transactions":[{"id":4633284,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-10-01T16:00:05.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":false,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":1843,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":921},"source":{"system":"sec-edgar","filing":"0001193125-26-409861","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409861/ownership.xml","form_type":"4"}},{"id":4633283,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-01T16:00:05.000Z","date":"2026-10-01","kind":"exercise","planned":false,"acquired":true,"shares":921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":1843,"source":{"system":"sec-edgar","filing":"0001193125-26-409861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526409861/ownership.xml","form_type":"4"}},{"id":721881,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-01T20:30:21.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."}],"balance_after":2764,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":922},"source":{"system":"sec-edgar","filing":"0001193125-26-292654","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292654/ownership.xml","form_type":"4"}},{"id":721880,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-01T20:30:21.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the issuer's Common Stock."}],"balance_after":922,"source":{"system":"sec-edgar","filing":"0001193125-26-292654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526292654/ownership.xml","form_type":"4"}},{"id":775700,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:10:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest monthly over 24 months from the grant date in substantially equaly monthly increments."}],"balance_after":1600,"derivative":{"exercise_price":5.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001193125-26-228922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228922/ownership.xml","form_type":"4"}},{"id":775699,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-18T20:10:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest monthly over 12 months from the grant date in substantially equal monthly increments, provided that the options vest in full on the Issuer's 2027 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":3686,"derivative":{"exercise_price":5.76,"expiration_date":"2036-05-14","underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228922/ownership.xml","form_type":"4"}},{"id":775698,"issuer":{"id":7637,"kind":"organization","name":"CERENOME, INC."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T20:10:01.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":3686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter."}],"balance_after":3686,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3686},"source":{"system":"sec-edgar","filing":"0001193125-26-228922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526228922/ownership.xml","form_type":"4"}},{"id":935838,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T21:25:16.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":568,"price":17.58,"value":9985.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A is being filed to correct the reporting person's aggregate beneficial ownership, which was understated by 88 shares in the original Form 4 filed on October 15, 2025 due to an administrative reporting error. No additional transactions occurred other than those previously reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct the reporting person's aggregate beneficial ownership, which was understated by 88 shares in the original Form 4 filed on October 15, 2025 due to an administrative reporting error. No additional transactions occurred other than those previously reported."}],"balance_after":15796,"source":{"system":"sec-edgar","filing":"0001104659-26-005081","document":"tm263642-10_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465926005081/tm263642-10_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-10-16"}},{"id":947682,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T21:30:30.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer and has an exercise price of $23.82 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance."}],"balance_after":1500,"derivative":{"exercise_price":23.82,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-26-001334","document":"tm261953-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465926001334/tm261953-1_4seq1.xml","form_type":"4"}},{"id":1017785,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T20:30:17.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":568,"price":17.58,"value":9985.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"568 shares of common stock were granted upon the close of business on October 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-25."}],"balance_after":15708,"source":{"system":"sec-edgar","filing":"0001104659-25-100104","document":"tm2528907-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925100104/tm2528907-1_4seq1.xml","form_type":"4"}},{"id":1084874,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-18T20:36:53.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":676,"price":14.78,"value":9991.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"676 shares of common stock were granted upon the close of business on July 16, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-25."}],"balance_after":15228,"source":{"system":"sec-edgar","filing":"0001104659-25-069057","document":"tm2521234-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925069057/tm2521234-3_4seq1.xml","form_type":"4"}},{"id":1170115,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-17T21:02:25.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":1785,"price":5.6,"value":9996.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1,785 shares of common stock were granted upon the close of business on April 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25."}],"balance_after":14552,"source":{"system":"sec-edgar","filing":"0001104659-25-036085","document":"tm2512512-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925036085/tm2512512-3_4seq1.xml","form_type":"4"}},{"id":1301712,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-16T22:17:09.000Z","date":"2025-01-14","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance."}],"balance_after":1000,"derivative":{"exercise_price":6.06,"expiration_date":"2035-01-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001104659-25-004164","document":"tm253548-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925004164/tm253548-5_4seq1.xml","form_type":"4"}},{"id":1301709,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-16T22:15:13.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":1639,"price":6.1,"value":9997.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1,639 shares of common stock were granted upon the close of business on January 15, 2025, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-24."}],"balance_after":12767,"source":{"system":"sec-edgar","filing":"0001104659-25-004156","document":"tm253548-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465925004156/tm253548-1_4seq1.xml","form_type":"4"}},{"id":1385142,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-17T20:34:15.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":1510,"price":6.62,"value":9996.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,510s hares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24."}],"balance_after":11128,"source":{"system":"sec-edgar","filing":"0001104659-24-109550","document":"tm2426435d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924109550/tm2426435d1_4seq1.xml","form_type":"4"}},{"id":1413036,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":2000,"derivative":{"exercise_price":6.56,"expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413035,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":30.8,"expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413034,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":1250,"derivative":{"exercise_price":6.56,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413033,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":64.4,"expiration_date":"2031-03-08","underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413032,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":258,"derivative":{"exercise_price":6.56,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":258},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413031,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":52,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":258},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413030,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The exercise price of the option is $6.56 per share, representing the fair market value per share of the Issuer's Common Stock on the Effective Date; provided that the repriced option will revert to its original exercise price if, prior to the first anniversary of the Effective Date, (a) the Reporting Person's service with the Issuer is terminated by the Issuer with cause or by the Reporting Person or (b) the option is exercised."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":103,"derivative":{"exercise_price":6.56,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":103},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1413029,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-06T21:11:36.000Z","date":"2024-08-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 30, 2024, the Issuer's Board of Directors approved an option repricing (the \"Repricing\"), effective as of August 31, 2024 (the \"Effective Date\"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award was issued pursuant to the Company's Amended and Restated 2017 Stock Option and Incentive Plan, as amended, (the \"2017 Plan\") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":52,"expiration_date":"2031-03-02","underlying":"Common Stock","underlying_shares":103},"source":{"system":"sec-edgar","filing":"0001104659-24-097790","document":"tm2423539-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924097790/tm2423539-6_4seq1.xml","form_type":"4"}},{"id":1453977,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T20:30:12.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":2157,"price":4.63,"value":9986.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"2,157 shares of common stock were granted upon the close of business on July 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-24."}],"balance_after":9618,"source":{"system":"sec-edgar","filing":"0001104659-24-080213","document":"tm2419567-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924080213/tm2419567-1_4seq1.xml","form_type":"4"}},{"id":1469807,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:02:10.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance"}],"balance_after":1000,"derivative":{"exercise_price":4.98,"expiration_date":"2034-06-21","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001104659-24-074788","document":"tm2418227-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924074788/tm2418227-1_4seq1.xml","form_type":"4"}},{"id":1540355,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-17T20:21:08.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":3153,"price":6.66,"value":20998.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"3,153 shares of common stock were granted upon the close of business on April 15, 2024, as a consideration in lieu of cash payment of deferred compensation for service as a member of the Board of Directors for Q4-23 and Q1-24. The price reported in Column 4 is a weighted average price ranging from $5.35 to $6.74. The reporting person undertakes to provide, upon request, full information regarding the number of shares calculated at each separate price within the range set forth in this footnote."}],"balance_after":7461,"source":{"system":"sec-edgar","filing":"0001104659-24-048320","document":"tm2412083-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465924048320/tm2412083-2_4seq1.xml","form_type":"4"}},{"id":1754839,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-26T20:30:25.000Z","date":"2023-10-24","kind":"grant","planned":false,"acquired":true,"shares":4005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 4,005 shares of common stock were granted upon the close of business on October 24, 2023 as consideration in lieu of cash payment of deferred compensation for service as a member of the Board of Directors."}],"balance_after":4308,"source":{"system":"sec-edgar","filing":"0001104659-23-111758","document":"tm2329242-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923111758/tm2329242-3_4seq1.xml","form_type":"4"}},{"id":1781266,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T20:39:13.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":true,"shares":6060,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The 6,060 restricted shares of common stock were granted upon the close of business on September 12, 2023 and vested immediately upon issuance.  The restricted shares were issued as consideration in lieu of cash payment of deferred compensation for service as a member of the Board of Directors."}],"balance_after":6060,"source":{"system":"sec-edgar","filing":"0001104659-23-100810","document":"tm2326171-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923100810/tm2326171-1_4seq1.xml","form_type":"4"}},{"id":2057863,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-10T21:42:22.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance"}],"balance_after":30000,"derivative":{"exercise_price":0.62,"expiration_date":"2033-01-06","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-23-002759","document":"tm233036-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465923002759/tm233036-1_4seq1.xml","form_type":"4"}},{"id":2091029,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest (and thereby become exercisable) as follows: (i) one-third on December 31, 2022, (ii) one-third on January 31, 2023, and (iii) one-third on February 28, 2023 (each such date, a \"Vesting Date\"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date."}],"balance_after":50000,"derivative":{"exercise_price":0.4644,"expiration_date":"2032-12-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091028,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Restricted Stock Units","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091027,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Restricted Stock Units","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."}],"balance_after":250000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091026,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Restricted Stock Units","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091025,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":93750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":281250,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091024,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.15,"underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091023,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":5.34,"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091022,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":1.68,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091021,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.51,"underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091020,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.4,"underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091019,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.1,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2091018,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CEO"}}],"security":"Common Stock, no par value","published_at":"2022-12-10T01:23:24.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":583212,"source":{"system":"sec-edgar","filing":"0001493152-22-035089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222035089/ownership.xml","form_type":"4"}},{"id":2179398,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock, no par value","published_at":"2022-08-18T20:05:43.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":40000,"price":0.96,"value":38400.0,"ownership":{"direct":true},"balance_after":333212,"source":{"system":"sec-edgar","filing":"0001493152-22-023462","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222023462/ownership.xml","form_type":"4"}},{"id":2326979,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2022-03-18T01:26:55.000Z","date":"2022-03-16","kind":"purchase","acquired":true,"shares":50000,"price":1.283,"value":64150.0,"ownership":{"direct":true},"balance_after":293212,"source":{"system":"sec-edgar","filing":"0001493152-22-007205","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007205/ownership.xml","form_type":"4"}},{"id":2327022,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-18T01:24:56.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units will vest immediately upon the Issuer's achievement with respect to pre-defined market capitalization objectives and product-related milestones during the period beginning on January 1, 2022 and ending on December 31, 2024, subject to continuous service through the applicable vesting date. The number of restricted stock units that will vest will be determined based on the Issuer's level of achievement with respect to such pre-defined milestones. If such pre-defined milestones are not achieved at a minimum level, no vesting will occur and the restricted stock units will be cancelled."}],"balance_after":500000,"derivative":{"exercise_price":0,"expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-22-007202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007202/ownership.xml","form_type":"4"}},{"id":2327021,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-18T01:24:56.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":0,"exercise_date":"2023-03-15","expiration_date":"2023-03-15","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-22-007202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007202/ownership.xml","form_type":"4"}},{"id":2327020,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-18T01:24:56.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest subject to the Issuer's achievement of pre-defined product-related milestones and financial performance and corporate budget objectives in 2022. The number of options that will vest will be determined based on the Issuer's level of achievement in 2022 with respect to such pre-defined objectives. If such pre-defined objectives are not achieved at a minimum level, no vesting will occur and the options will be cancelled. Options will vest in annual installments over three years from the effective date of grant, if such pre-defined objectives have been achieved in 2022, subject to continuous service through the applicable vesting date."}],"balance_after":375000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001493152-22-007202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007202/ownership.xml","form_type":"4"}},{"id":2327019,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-18T01:24:56.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest subject to the Issuer's achievement of pre-defined product development, regulatory and financial goals in 2022. 100% of the options will vest on December 31, 2023, if such pre-defined goals have been achieved in 2022, subject to continuous service through the vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-22-007202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007202/ownership.xml","form_type":"4"}},{"id":2327018,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2022-03-18T01:24:56.000Z","date":"2022-03-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.15,"expiration_date":"2032-03-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-22-007202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315222007202/ownership.xml","form_type":"4"}},{"id":2436150,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-13T22:05:56.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one month anniversary of the date of the issuance"}],"balance_after":40000,"derivative":{"exercise_price":1.54,"expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-22-004058","document":"tm222906-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465922004058/tm222906-1_4seq1.xml","form_type":"4"}},{"id":2613470,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-05T21:35:34.000Z","date":"2021-08-03","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in twelve equal monthly installments beginning on the one month anniversary of the date of the issuance"}],"balance_after":25000,"derivative":{"exercise_price":3.22,"expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-100857","document":"tm2124311-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465921100857/tm2124311-1_4seq1.xml","form_type":"4"}},{"id":2644171,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-03T01:32:23.000Z","date":"2021-07-01","kind":"exercise","acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on July 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on July 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-21-016130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221016130/ownership.xml","form_type":"4"}},{"id":2644170,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2021-07-03T01:32:23.000Z","date":"2021-07-01","kind":"tax_withholding","acquired":false,"shares":15834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 65,000 Restricted Stock Units."}],"balance_after":243212,"source":{"system":"sec-edgar","filing":"0001493152-21-016130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221016130/ownership.xml","form_type":"4"}},{"id":2644169,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2021-07-03T01:32:23.000Z","date":"2021-07-01","kind":"exercise","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":259046,"source":{"system":"sec-edgar","filing":"0001493152-21-016130","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221016130/ownership.xml","form_type":"4"}},{"id":2644168,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-07-02T17:59:02.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":106221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on May 7, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on May 7, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":106221},"source":{"system":"sec-edgar","filing":"0001493152-21-015984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221015984/ownership.xml","form_type":"4"}},{"id":2644167,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2021-07-02T17:59:02.000Z","date":"2021-06-30","kind":"tax_withholding","acquired":false,"shares":25873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 106,221 Restricted Stock Units."}],"balance_after":194046,"source":{"system":"sec-edgar","filing":"0001493152-21-015984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221015984/ownership.xml","form_type":"4"}},{"id":2644166,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2021-07-02T17:59:02.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":106221,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":219919,"source":{"system":"sec-edgar","filing":"0001493152-21-015984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221015984/ownership.xml","form_type":"4"}},{"id":2776131,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2021-03-22T21:17:49.000Z","date":"2021-03-19","kind":"purchase","acquired":true,"shares":11000,"price":4.7911,"value":52702.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at various prices ranging from $4.76 to $4.81."}],"balance_after":113698,"source":{"system":"sec-edgar","filing":"0001493152-21-006546","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221006546/ownership.xml","form_type":"4"}},{"id":2791673,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":9494,"price":9.04,"value":85825.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791672,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":9.5,"value":70841.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.5,"expiration_date":"2025-11-04","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791671,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":14914,"price":9.5,"value":141683.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":12.5,"expiration_date":"2025-11-04","underlying":"Ordinary Shares","underlying_shares":14914},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791670,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.56,"value":56374.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791669,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.51,"value":56002.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.49,"expiration_date":"2028-06-19","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791668,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":7.54,"value":56225.78,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":14.46,"expiration_date":"2027-06-06","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791667,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":7457,"price":13.35,"value":99550.95,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price."}],"balance_after":0,"derivative":{"exercise_price":8.65,"expiration_date":"2026-06-28","underlying":"Ordinary Shares","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2791666,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2021-03-12T21:35:37.000Z","date":"2021-03-08","kind":"disposition_to_issuer","acquired":false,"shares":4081,"price":22,"value":89782.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the \"Scheme\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001140361-21-008340","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000114036121008340/form4.xml","form_type":"4"}},{"id":2809414,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-04T20:08:40.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":5171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 1, 2021 (the \"Effective Date\"), Mr. Ron A. Andrews (the \"Reporting Person\") was appointed to the Board of Directors of Precipio, Inc. (the \"Company\"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an \"Option\" and together, the \"Options\") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 1, 2021 (the \"Effective Date\"), Mr. Ron A. Andrews (the \"Reporting Person\") was appointed to the Board of Directors of Precipio, Inc. (the \"Company\"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an \"Option\" and together, the \"Options\") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option vests in thirty-six equal monthly installments beginning on the Effective Date."}],"balance_after":5.171,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":5171},"source":{"system":"sec-edgar","filing":"0001104659-21-032065","document":"tm215617d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465921032065/tm215617d2_4.xml","form_type":"4"}},{"id":2809413,"issuer":{"id":7207,"kind":"organization","name":"Precipio, Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-04T20:08:40.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":2069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 1, 2021 (the \"Effective Date\"), Mr. Ron A. Andrews (the \"Reporting Person\") was appointed to the Board of Directors of Precipio, Inc. (the \"Company\"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an \"Option\" and together, the \"Options\") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 1, 2021 (the \"Effective Date\"), Mr. Ron A. Andrews (the \"Reporting Person\") was appointed to the Board of Directors of Precipio, Inc. (the \"Company\"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person options (each an \"Option\" and together, the \"Options\") to purchase 2,069 and 5,171 shares, respectively, of the Company's common stock, par value $0.01 per share, both at an exercise price of $2.60 (the closing price of the Company's common stock on the Effective Date)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option vests in twelve equal monthly installments beginning on the Effective Date."}],"balance_after":2069,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":2069},"source":{"system":"sec-edgar","filing":"0001104659-21-032065","document":"tm215617d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1043961/000110465921032065/tm215617d2_4.xml","form_type":"4"}},{"id":2825942,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-01T21:28:08.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":500000,"price":5.34,"value":2670000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting: Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date."}],"balance_after":500000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-21-005098","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315221005098/ownership.xml","form_type":"4"}},{"id":3069368,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, no par value","published_at":"2020-08-04T22:50:42.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":40000,"price":1.347,"value":53880.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at various prices ranging from $1.32 to $1.40."}],"balance_after":102698,"source":{"system":"sec-edgar","filing":"0001493152-20-014613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220014613/ownership.xml","form_type":"4"}},{"id":3098373,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-26T20:05:32.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":9494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under Issuer's 2013 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will vest and become exercisable as to 100% of the underlying shares on the earlier of the first anniversary of the date of grant or the date of the first annual general meeting of the shareholders held after the date of grant."}],"balance_after":9494,"derivative":{"exercise_price":12.96,"expiration_date":"2030-06-24","underlying":"Ordinary Shares","underlying_shares":9494},"source":{"system":"sec-edgar","filing":"0001437749-20-013988","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000143774920013988/rdgdoc.xml","form_type":"4"}},{"id":3098372,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"Ordinary Shares","published_at":"2020-06-26T20:05:32.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":4081,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4081,"source":{"system":"sec-edgar","filing":"0001437749-20-013988","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000143774920013988/rdgdoc.xml","form_type":"4"}},{"id":3152510,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-05-12T18:25:52.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":106221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant."}],"balance_after":106221,"derivative":{"underlying":"Common Stock","underlying_shares":106221},"source":{"system":"sec-edgar","filing":"0001493152-20-008357","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220008357/ownership.xml","form_type":"4"}},{"id":3188944,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock, no par value","published_at":"2020-04-02T01:24:57.000Z","date":"2020-03-31","kind":"purchase","acquired":true,"shares":18000,"price":2.372,"value":42696.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Amendment to correct March 31, 2020 share purchase price by replacing erroneous comma with a decimal point."}],"balance_after":62698,"source":{"system":"sec-edgar","filing":"0001493152-20-005646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220005646/ownership.xml","form_type":"4/A","original_submission_date":"2020-04-01"}},{"id":3188943,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock, no par value","published_at":"2020-04-02T01:24:57.000Z","date":"2020-03-30","kind":"purchase","acquired":true,"shares":27216,"price":2.258,"value":61453.728,"ownership":{"direct":true},"balance_after":44698,"source":{"system":"sec-edgar","filing":"0001493152-20-005646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220005646/ownership.xml","form_type":"4/A","original_submission_date":"2020-04-01"}},{"id":3188942,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock, no par value","published_at":"2020-04-01T20:05:28.000Z","date":"2020-03-31","kind":"purchase","acquired":true,"shares":18000,"price":2372,"value":42696000.0,"ownership":{"direct":true},"balance_after":62698,"source":{"system":"sec-edgar","filing":"0001493152-20-005608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220005608/ownership.xml","form_type":"4"}},{"id":3188941,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock, no par value","published_at":"2020-04-01T20:05:28.000Z","date":"2020-03-30","kind":"purchase","acquired":true,"shares":27216,"price":2.258,"value":61453.728,"ownership":{"direct":true},"balance_after":44698,"source":{"system":"sec-edgar","filing":"0001493152-20-005608","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315220005608/ownership.xml","form_type":"4"}},{"id":3467744,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-03T22:44:52.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter of the options shall vest upon the completion of one year of continuous service from the date of grant on July 1, 2019 and the balance shall vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, based on continuous service on the applicable vesting date."}],"balance_after":950000,"derivative":{"exercise_price":2.51,"expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001209191-19-041282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000120919119041282/doc4.xml","form_type":"4"}},{"id":3483952,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2019-06-19T20:30:33.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.44,"expiration_date":"2029-06-18","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-19-012282","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000143774919012282/rdgdoc.xml","form_type":"4"}},{"id":3827157,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-09-05T01:40:51.000Z","date":"2018-08-30","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.4,"expiration_date":"2028-08-29","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-049412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000120919118049412/doc4.xml","form_type":"4"}},{"id":3857751,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock purchase warrants","published_at":"2018-08-01T01:39:56.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":17482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":17482,"derivative":{"exercise_price":3,"exercise_date":"2019-02-01","expiration_date":"2024-02-01","underlying":"Common stock","underlying_shares":17482},"source":{"system":"sec-edgar","filing":"0001493152-18-010765","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315218010765/ownership.xml","form_type":"4"}},{"id":3857750,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, no par value","published_at":"2018-08-01T01:39:56.000Z","date":"2018-07-26","kind":"purchase","acquired":true,"shares":17482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock and the common stock purchase warrants reported in this Form were purchased in \"units,\" with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86."}],"balance_after":17482,"source":{"system":"sec-edgar","filing":"0001493152-18-010765","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000149315218010765/ownership.xml","form_type":"4"}},{"id":3885975,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2018-06-21T20:30:28.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.49,"expiration_date":"2028-06-19","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-18-012232","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000143774918012232/rdgdoc.xml","form_type":"4"}},{"id":4288242,"issuer":{"id":141404,"kind":"organization","name":"Oxford Immunotec Global PLC","symbol":"OXFD"},"owners":[{"id":34216,"kind":"person","name":"ANDREWS RONALD ASBURY","position":1,"cik":"0001299153","reported_name":"ANDREWS RONALD ASBURY","relationship":{"director":true}}],"security":"SHARE OPTION (RIGHT TO BUY)","published_at":"2017-06-08T20:33:54.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant."}],"balance_after":7457,"derivative":{"exercise_price":14.46,"expiration_date":"2027-06-06","underlying":"ORDINARY SHARES","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001437749-17-010976","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1299153/000143774917010976/rdgdoc.xml","form_type":"4"}}]}